Type of Credit: Required
Credit(s)
Number of Students
一、主要討論內容:從Drug Discovery Today, Nature Biotechnology, JAMA Intern Med., N. Engl. J. Med., Nature Reviews Drug Discovery等期刊中,挑選出與最新科技、智慧財產權及相關判例、生技製藥產業經營管理、生技製藥創新創業、產學合作等議題相關的文章。
二、每堂課會由3-4位同學就3-4篇文章進行報告。課堂參與的老師,除了任課教師之外,另外有3-5位的專家學者參加(例如:陽明交大/政大相關系所老師、醫院主管、專利商標事務所律師與主管、生技製藥產業主管等)
能力項目說明
讓同學能就生技製藥範疇有機會進行跨領域(科技、智慧財產權、商業管理、創新創業等)的學習,以符合產業發展上的需求。
以下排課僅供參考,上課進度Class Schedule仍在規劃中,正式課程內容於第一堂課告知。
原則上一學期安排六堂課(每次三小時),分別在政大及陽明上課。
Date |
Topic |
Speaker |
政大 |
Can plant expression solve the biologics productivity delema |
|
Drug Discovery Today |
||
Federal judge scolds Purdue, Endo and Mallinckrodt for stall tactics in opioids case |
|
|
FiercePharma |
||
陽明 第二週 |
新北產業園區長安醫藥集團 |
|
Strategy as winner in drug discovery. 2. How to evaluate a biotech company ? |
||
政大 第三週 |
Prevent the real world from derailing your clinical trial |
|
Frenova |
||
Stock price effects of breakthrough therapy designation-licensing |
|
|
Nature Reviews Drug Discovery |
||
陽明 第四週 |
Roche, Biogen and AbbVie stake new gene therapy claims-licensing |
|
Nature Reviews Drug Discovery |
||
Trial hints at age clock reversa |
|
|
Nature |
||
政大 第五週 |
Trends in clinical success rates and therapeutic focus-licensing |
|
Nature Reviews Drug Discovery |
||
Unlocking the power of translational medicine-licensing- |
|
|
Nature Reviews Drug Discovery |
||
陽明 第六週 |
A novel approach to reverse proteinopathies, |
|
Nature Reviews Drug Discovery |
||
Added therapeutic benefit and drug licensing |
|
|
Nature Reviews Drug Discovery |
以課堂報告為主。